Solventum Corporation (NYSE:SOLV) Receives $91.64 Average Price Target from Analysts

Shares of Solventum Corporation (NYSE:SOLV) have earned an average rating of “Hold” from the thirteen research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating on the company. The average 1-year price objective among brokerages that have covered the stock in the last year is $91.6364.

A number of equities research analysts have recently issued reports on SOLV shares. Wells Fargo & Company dropped their price objective on Solventum from $83.00 to $70.00 and set an “equal weight” rating on the stock in a research note on Wednesday, May 6th. UBS Group raised their target price on shares of Solventum from $95.00 to $101.00 and gave the company a “buy” rating in a research note on Thursday, August 6th. Stifel Nicolaus boosted their target price on shares of Solventum from $90.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, August 6th. KeyCorp upped their price target on shares of Solventum from $93.00 to $102.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Finally, Mizuho set a $113.00 price target on shares of Solventum in a research note on Thursday, August 6th.

Institutional Investors Weigh In On Solventum

Hedge funds have recently bought and sold shares of the company. United Services Automobile Association bought a new stake in Solventum in the first quarter valued at approximately $239,000. Woodline Partners LP increased its holdings in shares of Solventum by 40.7% during the 1st quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock worth $888,000 after acquiring an additional 3,377 shares during the last quarter. Intech Investment Management LLC increased its holdings in shares of Solventum by 167.0% during the 1st quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock worth $1,268,000 after acquiring an additional 10,425 shares during the last quarter. First Trust Advisors LP increased its holdings in shares of Solventum by 5.8% during the 2nd quarter. First Trust Advisors LP now owns 257,727 shares of the company’s stock worth $19,546,000 after acquiring an additional 14,151 shares during the last quarter. Finally, Marshall Wace LLP bought a new stake in Solventum in the 2nd quarter valued at $766,000.

Solventum Price Performance

NYSE:SOLV opened at $88.53 on Friday. Solventum has a 52-week low of $62.38 and a 52-week high of $90.00. The company has a market cap of $15.07 billion, a P/E ratio of 10.82, a P/E/G ratio of 1.11 and a beta of 0.60. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.74 and a current ratio of 1.02. The stock’s 50-day simple moving average is $80.11 and its 200 day simple moving average is $74.67.

Solventum (NYSE:SOLV) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $1.91 by $0.64. The firm had revenue of $2.21 billion during the quarter, compared to analysts’ expectations of $2.15 billion. Solventum had a return on equity of 25.09% and a net margin of 17.26%.The business’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.69 earnings per share. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. As a group, sell-side analysts forecast that Solventum will post 7.22 EPS for the current fiscal year.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.